Welcome to Novo Nordisk in the United States


DAWN2™ Study

DAWN2™ (Diabetes Attitudes, Wishes and Needs) is a global partnership initiative for the advancement of patient-centered diabetes care, and represents the voice of more than 15,000 diabetes patients, family members, and health care providers. It uncovers psychosocial challenges faced by people living with diabetes and their family members. The study also provides the perspective of health care professionals as to barriers they see for helping their patients improve their self-management of diabetes.

The DAWN2™ study is a scientifically valid, cross-sectional survey with respondents from 17 countries across 4 continents, including the United States. It was conducted in collaboration with the International Diabetes Federation (IDF), the International Alliance of Patient Organizations (IAPO), the Steno Diabetes Center, and a range of other national, regional, and global partners.

The main objectives of the DAWN2™ study initiative are to:

  • Understand the unmet needs of people with diabetes and their families
  • Ensure patient involvement and psychosocial support in diabetes care
  • Develop an international benchmarking system for patient-centered diabetes care

Download the DAWN2™ infographic

Results from the global DAWN2™ study and more information are available here.






© 2016 Novo Nordisk All rights reserved. 0415-00026489-1 January 2016